Tenderwize
Zurück zur Suche

Open House Discount Contracts for Tofacitinib, ATC L04AF01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tofacitinib , ATC L04AF01

25/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

25 / 100

Komplexität

20 / 100

Risikofaktoren

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Tofacitinib (ATC L04AF01)
  • Open house model: any qualifying pharmaceutical company can join at any time
Vollständige Zusammenfassung anzeigen

AOK Rheinland-Pfalz/Saarland is offering non-exclusive discount contracts for the active substance Tofacitinib (ATC L04AF01) under an open house model. All interested pharmaceutical companies can join by submitting required documents. Contracts run from May 2025 to April 2027, with possible monthly entry. No estimated value is provided. The procedure is explicitly stated not to be a public procurement under EU directives.

Risiken

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical company with authorized and marketable medicines in Germany
  • Medicines must be listed in Lauer-Taxe or proven via AMIce database extracts

Administrative

  • Submit signed contract documents by specified deadlines for desired start date

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Contracts for Tofacitinib, ATC L04AF01

Non-exclusive discount contracts for Tofacitinib under an open house model. All interested pharmaceutical companies can enter at any time during the 24-month period. Contracts are non-negotiable, standard terms. Early termination possible if exclusive contracts are concluded.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Vergabedetails

Veröffentlichungsdatum
12 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
164834-2025

Dokumente (1)

Ähnliche Ausschreibungen